The Mesothelioma Guide Blog

Mesothelioma, an aggressive cancer made up of many tumors, is rarely controlled by the body’s natural defenses. Treatment, whether chemotherapy or surgery or another form, is...

Update: This post was updated March 4, 2022, with more hospitals approved to prescribe the Optune Lua therapy for mesothelioma.   Optune Lua, the brand name for Novocure’s...

The overall median survival figures about immunotherapy versus chemotherapy have been reported often for mesothelioma. A few other pieces of data stress how well the immunotherapy...

A New Jersey bankruptcy court judge ruled in favor of Johnson & Johnson – and against thousands of victims of corporate wrongdoing – by allowing the company to continue...

One victim of asbestos won a multi-million-dollar verdict. The court’s ruling feels like a win for many more than just one victim. Former mine worker Ralph H. received a $36.5...

Update (02/25/2022): Judge Michael Kaplan of the U.S. Bankruptcy Court in Trenton, N.J., sided with Johnson & Johnson in the case, according to numerous reports. He denied the...

Most systemic cancer treatment lasts a set number of cycles. These cycles are usually three-week stretches of time in between sessions of treatment. In most cases, systemic...

SMART, the acronym for surgery for mesothelioma after radiation therapy, is a groundbreaking protocol of treatment. Impressive life expectancy of 3-4 years should garnet more...

Durvalumab and tremelimumab work so well together for mesothelioma that most patients in a study are still alive two years after starting treatment. Baylor College of Medicine,...

A new report showed the ethnic and racial disparities in the patient population of oncology clinical trials. Researchers spent December 2020 to April 2021 examining all United...